No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: No difference in survival between fluorouracil, cisplatin, or carboplatin-based paclitaxel therapy for locally advanced esophageal squamous cell carcinoma

byTeddy Guo

March 9, 2022

in StudyGraphics

Reading Time: 1 min read

Click to read this study in JAMA Network Open.

RELATED REPORTS

The addition of a carboplatin to standard of care adjuvant chemotherapy improves survival outcomes in patients with high-risk, early-stage triple-negative breast cancer

Short-course personalized acoustic therapy may increase tinnitus remission in patients with idiopathic sudden sensorineural hearing loss

Paclitaxel-coated devices do not reduce rates of major amputations in chronic limb-threatening ischemia

Reliever-triggered inhaled glucocorticoid therapy in among Black and Latinx adults with asthma

RelatedReports

Age and breast cancer risk factors associated with false-positive mammography results

Chronic Disease

The addition of a carboplatin to standard of care adjuvant chemotherapy improves survival outcomes in patients with high-risk, early-stage triple-negative breast cancer

January 12, 2026

Bilateral diagonal earlobe creases associated with increased risk of coronary artery disease

Chronic Disease

Short-course personalized acoustic therapy may increase tinnitus remission in patients with idiopathic sudden sensorineural hearing loss

January 13, 2026

Novel biodegradable sirolimus-eluting stents non-inferior to durable everolimus-eluting stents [BIOSCIENCE trial]

Cardiology

Paclitaxel-coated devices do not reduce rates of major amputations in chronic limb-threatening ischemia

October 31, 2025

Gastric bypass surgery reduces cardio-metabolic risk factors

Chronic Disease

Endoscopic sinus surgery improves quality of life compared with clarithromycin and placebo in chronic rhinosinusitis

October 28, 2025

Tremor and memory symptoms prior to diagnosis demonstrate the strongest associations with subsequent Parkinson disease

Blindness and visual impairment decreasing worldwide

Faricimab noninferior to aflibercept for treatment of neovascular age-related macular degeneration

Decline in adolescent sleep duration over past 20 years

Wellness Check: Sleep

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result